M. Heidenrijk

Decreased Time to Viral Suppression After Implementation of Targeted Testing and Immediate Initiation of Treatment of Acute Human Immunodeficiency Virus Infection Among Men Who Have Sex With Men in Amsterdam

D., W., R. Koup, 2021 .

Promoting HIV indicator condition-guided testing in hospital settings (PROTEST 2.0): study protocol for a multicentre interventional study

T. van der Poll, M. V. van Zelm, R. Koup, 2021, BMC Infectious Diseases.

Effects of a subsidized voluntary health insurance on insured and uninsured in Nigeria

K., M. Hendriks, J. Lammers, 2015 .

High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis.

T. van der Poll, M. V. van Zelm, R. Koup, 2019, Journal of hepatology.

Research in Action: From AIDS to Global Health to Impact. A Symposium in Recognition of the Scientific Contributions of Professor Joep Lange

T. R. D. Wit, C. Schultsz, M. Kazatchkine, 2015, Antiviral therapy.

Is reaching 90-90-90 enough to end AIDS? Lessons from Amsterdam.

P. Reiss, M. Prins, M. van der Valk, 2019, Current opinion in HIV and AIDS.

High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid

C. Franceschi, B. Berkhout, R. Leech, 2017, Open forum infectious diseases.

Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2·0): A multicenter, interrupted time-series analysis

T. van der Poll, M. V. van Zelm, R. Koup, 2022, The Lancet regional health. Europe.

Digital health for all: How digital health could reduce inequality and increase universal health coverage

K. Stronks, G. Asiki, C. Agyemang, 2023, Digital health.

A 95% decline in estimated newly acquired HIV infections, Amsterdam, 2010 to 2022

J. Heijne, M. van der Valk, G. D. de Bree, 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.